United States Antimony UAMY Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Energy TransferET

$110M+19.6%

Ameriprise FinancialAMP

-$6M+53.8%

The Travelers CompaniesTRV

$23M-56.6%

NucorNUE

$7M+75.0%

ChubbCB

$157M+91.5%

Elevance HealthELV

$305M+142%

Other financials

Income statement

See full

Revenue$6.8M-3.1%

Gross profit$1.1M-53.2%

Operating income-$7.5M-2,200%

Net income-$11.3M-2,167%

EPS (diluted)-$0.08—

Balance sheet

See full

Cash & equivalents$3.2M-82.9%

Total debt$199.9K-40.0%

Total equity$131.9M+305%

Total assets$148.0M+275%

Cash flow

See full

Operating cash flow-$12.1M-597%

CapEx$12.6M+1,359%

Free cash flow-$24.6M-851%

Valuation

See full

Market cap$1.02B+213%

Enterprise value$1.01B+231%

P/S26×+8.8×

Profitability

See full

Gross margin22.1%-5.8pp

Operating margin-41.8%-55.5pp

Net margin-41.4%-47.3pp

FCF margin-152.5%-157pp

Returns & leverage

See full

Return on equity-19.7%-23.9pp

Debt / equity0×0.0×

Current ratio3.6×-1.6×

Where this comes from

Reported directly by United States Antimony in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: United States Antimony’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about United States Antimony's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is United States Antimony's equity in earnings (losses) of equity method investees?: United States Antimony (UAMY) reported equity in earnings (losses) of equity method investees of -$16.13K in Q1 2026.